Literature DB >> 15663360

Regulation, regulatory activities, and function of biglycan.

Sunil Wadhwa1, Mildred C Embree, Yanming Bi, Marian F Young.   

Abstract

Biglycan is a member of the small leucine repeat proteoglycan family (SLRP). The biglycan gene is located on the X chromosome. Based on the amino acid sequence, the protein core of biglycan can be divided into six distinct domains: (1) a signal sequence, (2) a propeptide region, (3) a N-terminal glycosaminoglycan attachment region, (4) a cysteine loop, followed by (5) a leucine- rich repeat region domain (that makes up over 66% of the core protein), and (6) a final cysteine loop. Biglycan has been found in almost every organ within our body, but it is not uniformly distributed within an organ. Biglycan has been shown to be expressed on the cell surface, pericellularly, and sometimes within the extracellular matrices of a range of specialized cell types within the organ. Its expression pattern has been shown to be altered by growth factors and certain pathologic conditions. The regulation of biglycan expression occurs by both transcriptional and nontranscriptional mechanisms. The currently proposed biglycan functions appear to be dependent on the particular microenvironment and on the organ in question. In this review, we will focus on gene and protein structure, localization, expression, regulation, and function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663360     DOI: 10.1615/critreveukaryotgeneexpr.v14.i4.50

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  16 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

2.  Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells.

Authors:  William E Lowry; Cedric Blanpain; Jonathan A Nowak; Geraldine Guasch; Lisa Lewis; Elaine Fuchs
Journal:  Genes Dev       Date:  2005-06-16       Impact factor: 11.361

Review 3.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

4.  Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice.

Authors:  Sunil Wadhwa; Yanming Bi; Ana T Ortiz; Mildred C Embree; Tina Kilts; Renato Iozzo; Lynne A Opperman; Marian F Young
Journal:  Bone       Date:  2006-12-26       Impact factor: 4.398

5.  Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer.

Authors:  Xiaojing Xing; Xiaohu Gu; Tianfei Ma; Huinan Ye
Journal:  Tumour Biol       Date:  2014-11-05

6.  A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin.

Authors:  Megan L Calmus; Elyse E Macksoud; Richard Tucker; Renato V Iozzo; Beatrice E Lechner
Journal:  Reproduction       Date:  2011-04-18       Impact factor: 3.906

Review 7.  The basic science of tendinopathy.

Authors:  Yinghua Xu; George A C Murrell
Journal:  Clin Orthop Relat Res       Date:  2008-05-14       Impact factor: 4.176

8.  Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.

Authors:  Payam Nahid; Erin Bliven-Sizemore; Leah G Jarlsberg; Mary A De Groote; John L Johnson; Grace Muzanyi; Melissa Engle; Marc Weiner; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  Tuberculosis (Edinb)       Date:  2014-02-07       Impact factor: 3.131

Review 9.  Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.

Authors:  Michael S Shawky; Carmela Ricciardelli; Megan Lord; John Whitelock; Vito Ferro; Kara Britt; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-12       Impact factor: 2.673

10.  High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Ying-Hui Zhu; Fu Yang; Shui-Shen Zhang; Ting-Ting Zeng; Xuan Xie; Xin-Yuan Guan
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.